Zymeworks Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
ZYME Nasdaq 2834 www.zymeworks.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Zymeworks Inc.

Gandeeva and Zymeworks Use Cryo-EM to Accelerate Antibody Drug Discovery - Jun 18th, 2026 6:00 am
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Monday Amid US-Iran Ceasefire - Jun 15th, 2026 6:56 am
Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological Cancers Congress 2026 - Jun 14th, 2026 4:05 pm
Zymeworks Announces Share Repurchase Program of up to $125 Million of its Common Stock - May 14th, 2026 2:05 pm
Zymeworks Announces Participation in Upcoming Investor Conferences - May 13th, 2026 4:00 am
Here's What Analysts Are Forecasting For Zymeworks Inc. (NASDAQ:ZYME) After Its First-Quarter Results - May 11th, 2026 6:32 am
A Look At Zymeworks (ZYME) Valuation After Earnings Miss And Key FDA And Capital Return Updates - May 9th, 2026 3:24 pm
Zymeworks Q1 Earnings Call Highlights - May 9th, 2026 3:05 am
Zymeworks Inc. Q1 2026 Earnings Call Summary - May 8th, 2026 6:30 am
Zymeworks Inc. (ZYME) Reports Q1 Loss, Misses Revenue Estimates - May 7th, 2026 5:05 pm
Zymeworks Provides Corporate Update and Reports First Quarter 2026 Financial Results - May 7th, 2026 2:05 pm
Royalty Pharma Q1 Earnings Call Highlights - May 6th, 2026 2:42 pm
uniQure (QURE) Reports Q1 Loss, Misses Revenue Estimates - May 5th, 2026 6:25 am
Vertex Pharmaceuticals (VRTX) Q1 Earnings and Revenues Beat Estimates - May 4th, 2026 3:20 pm
April 2026's Top 3 Stocks That May Be Trading Below Estimated Fair Value - Apr 27th, 2026 11:38 am
Zymeworks Highlights Royalty-Fueled Pivot at Bloom Burton, Eyes Multibillion-Dollar Ziihera - Apr 26th, 2026 1:12 am
Capricorn Fund Managers Dumps $18.4 Million Worth of Waystar Stock in Q1 - Apr 24th, 2026 11:07 am
Zymeworks Presents New Phase 1 Data for ZW191, a Folate Receptor Alpha-Targeting ADC at AACR Annual Meeting 2026 - Apr 21st, 2026 3:30 pm
Zymeworks Presents New Preclinical Data at AACR 2026 Highlighting Broad Antibody-Drug Conjugate Programs Including Novel RAS-Targeting Platform - Apr 17th, 2026 1:00 pm
How Investors May Respond To Zymeworks (ZYME) Hiring EcoR1 Executives To Lead R&D And Deals - Apr 17th, 2026 1:04 am